142.89  -0.707 (-0.49%)		10-28 15:56
Open: 143.265 High: 143.28 Volume: 1,712		Pre. Close: 143.597 Low: 141.755 Market Cap: 282(M)

Short term
Mid term
Targets	6-month :	168.4	1-year :	196.7
Resists	First :	144.18	Second :	168.4
Pivot price	141.79
Supports	First :	140.27	Second :	137.86
MAs	MA(5) :	143.26	MA(20) :	141.63
	MA(100) :	145.79	MA(250) :	133.82
MACD	MACD :	-0.1	Signal :	-0.6
%K %D	K(14,3) :	77.6	D(3) :	81
RSI	RSI(14): 51.7
52-week	High :	153.2	Low :	108.18

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ RZV ] has closed below upper band by 27.0%. Bollinger Bands are 34.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	143.46 - 144.16	144.16 - 144.85
Low:	139.67 - 140.56	140.56 - 141.43
Close:	141.24 - 142.65	142.65 - 144.04

The Invesco S&P SmallCap 600 Pure Value ETF is designed to mirror the performance of the S&P SmallCap 600 Pure Value Index. This fund allocates a minimum of 90% of its total assets to the securities comprising its benchmark index. The index itself tracks the financial performance of small-capitalization companies, drawn from the broader S&P SmallCap 600 Index, that exhibit pronounced value characteristics. These value traits are identified through key financial ratios, specifically book value-to-price, earnings-to-price, and sales-to-price. Both the fund's portfolio and the underlying index undergo adjustments annually.

Tue, 27 Oct 2026
Invesco Posts Solid Q3 Earnings as Revenue Grows 16.5% - Commercial Observer

Tue, 27 Oct 2026
Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool

Tue, 27 Oct 2026
Tranche Update on Invesco Ltd.'s Equity Buyback Plan announced on July 28, 2016. - www.marketscreener.com

Tue, 27 Oct 2026
Invesco Q3 Earnings Miss Estimates Despite Y/Y Revenue & AUM Growth - TradingView

Mon, 26 Oct 2026
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT? - The Motley Fool

Mon, 26 Oct 2026
Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy? - The Motley Fool

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management - Global
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.